Understanding Keratoconus and Its Early Treatment | AAO 2025 | Managed Healthcare Executive
Understanding Keratoconus and Its Early Treatment | AAO 2025 | Managed Healthcare Executive
6 months ago
managedhealthcareexecutive.com
Earlier dementia diagnosis could improve care, reduce downstream costs | Managed Healthcare Executive
Earlier dementia diagnosis could improve care, reduce downstream costs | Managed Healthcare Executive
1 month ago
managedhealthcareexecutive.com
ADA Accommodations and CGM Device Types: A Closer Look | Managed Healthcare Executive
ADA Accommodations and CGM Device Types: A Closer Look | Managed Healthcare Executive
1 week ago
managedhealthcareexecutive.com
An overview of the prevalence and treatment of multiple myeloma | Managed Healthcare Executive
An overview of the prevalence and treatment of multiple myeloma | Managed Healthcare Executive
1 week ago
managedhealthcareexecutive.com
Smile Omni Executes at Scale to Turn Intelligence Into Impact | Managed Healthcare Executive
Smile Omni Executes at Scale to Turn Intelligence Into Impact | Managed Healthcare Executive
1 month ago
managedhealthcareexecutive.com
Treatment Landscape of Crohn’s Disease and Mechanisms of Action | Managed Healthcare Executive
Treatment Landscape of Crohn’s Disease and Mechanisms of Action | Managed Healthcare Executive
7 months ago
managedhealthcareexecutive.com
Facing the practical problems of gene therapy | AMCP Annual 2026 | Managed Healthcare Executive
Facing the practical problems of gene therapy | AMCP Annual 2026 | Managed Healthcare Executive
1 week ago
managedhealthcareexecutive.com
Scripius Saw 86% Net Cost Reduction After Switching to Stelara Biosimilars | Managed Healthcare Executive
7 months ago
managedhealthcareexecutive.com
Exploring Nintedanib and Pirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis | Managed Healthcare Executive
Feb 13, 2025
managedhealthcareexecutive.com
A look at past and present HIV prevention therapies | AMCP Annual 2026 | Managed Healthcare Executive
2 weeks ago
managedhealthcareexecutive.com
Long-Term Repigmentation Outcomes and Real-World Use of Ruxolitinib Cream | Managed Healthcare Executive
1 week ago
managedhealthcareexecutive.com
Interpreting EMPOWER-Lung 3: Key Endpoints and Confidence in Cemiplimab-Based Therapy | Managed Healthcare Executive
1 week ago
managedhealthcareexecutive.com
Understanding “Delinking” in the PBM Legislation | AMCP 2024 | Managed Healthcare Executive
Apr 16, 2024
managedhealthcareexecutive.com
Orexin agonists among “exciting” emerging therapies for narcolepsy type 1 | AMCP Annual 2026 | Managed Healthcare Executive
1 week ago
managedhealthcareexecutive.com
The trend toward post-infusion outpatient care of patients treated with CAR-T | ASH 2025 | Managed Healthcare Executive
4 months ago
managedhealthcareexecutive.com
VDPHL01 shows faster, stronger hair growth vs standard minoxidil, CEO says | AAD 2026 | Managed Healthcare Executive
1 month ago
managedhealthcareexecutive.com
Both the types of medications and the sheer number can lead to adverse drug events after hospitalization | Managed Healthcare Executive
1 month ago
managedhealthcareexecutive.com
Payers, pharmacists' key to expanding access to precision medicine and liquid biopsy | AMCP Annual 2026 | Managed Healthcare Executive
2 weeks ago
managedhealthcareexecutive.com
The three areas of a patient’s PrEP journey where managed care organizations can be beneficial | AMCP Annual 2026 | Managed Healthcare Executive
2 weeks ago
managedhealthcareexecutive.com
Spending on behavioral health 'blew the doors off' of the funding system. Now the state of Oregon and CareOregon are figuring what to do, says CareOregon president and CEO Eric C.Hunter | Managed Healthcare Executive
1 month ago
managedhealthcareexecutive.com
The idea of value-based care appeals to dermatologists. The current reality? Not so much, says Marta J. Van Beek, M.D., M.P.H. | AAD 2026 | Managed Healthcare Executive
1 month ago
managedhealthcareexecutive.com
Examining Therapies Used in Later Lines of Treatment in ER /HER2- Metastatic Breast Cancer | Managed Healthcare Executive
6 months ago
managedhealthcareexecutive.com
Scale helps but is not necessary to value-based care practices, says Risant Health CEO Jaewon Ryu, M.D., J.D. | Managed Healthcare Executive
2 months ago
managedhealthcareexecutive.com
Care Without Delay program, 'succinct' value-based guides are key to Risant Health's value-based care push, says CEO Jaewon Ryu, M.D., J.D. | Managed Healthcare Executive
1 month ago
managedhealthcareexecutive.com
Value-based care practices shift the 'center of gravity' of healthcare to prevention and early recognition of disease, says Jaewon Ryu, M.D., J.D., CEO of Risant Health | Managed Healthcare Executive
1 month ago
managedhealthcareexecutive.com
Aspirin for colorectal cancer prevention: Current use and its limitations | 2026 ASCO Gastrointestinal Cancers Symposium | Managed Healthcare Executive
3 months ago
managedhealthcareexecutive.com
GLP-1s are associated with lower colorectal cancer incidence. Why that might be | 2026 ASCO Gastrointestinal Cancers Symposium | Managed Healthcare Executive
3 months ago
managedhealthcareexecutive.com
Fulton County Leaders Discuss Closing Health Gaps and Strengthening Behavioral Health Systems | Managed Healthcare Executive
5 months ago
managedhealthcareexecutive.com
76% of Autoimmune Patients Receive at Least One Misdiagnosis, Study Shows | Managed Healthcare Executive
8 months ago
managedhealthcareexecutive.com
Evolving Guidelines: Impact of Gene Therapy and BCG Failure Redefinitions on High-Risk NMIBC Patient Management | Managed Healthcare Executive
9 months ago
managedhealthcareexecutive.com
See more